Navigation Links
Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
Date:9/18/2012

ALISO VIEJO, Calif., Sept. 18, 2012 /PRNewswire/ -- Sequent Medical, Inc. announced today the award by the U.S. Patent and Trademark Office of Patent No. 8,261,648, entitled "Braiding Mechanism and Method of Use."

The company has developed proprietary MicroBraid™ technology to create the WEB® Aneurysm Embolization System.  MicroBraid technology allows the fabrication of fine wire braided devices, such as the WEB, that optimize key properties of porosity, radial compliance, and collapsed profile.

Building on the experience with endovascular embolic coils, the WEB enables physicians to treat intracranial aneurysms with the familiarity of an intra-saccular approach using established biomaterials.  The WEB is designed to bridge the aneurysm neck and to promote rapid peri-procedural stasis in both ruptured and un-ruptured aneurysms.  The initial WEB configurations offer a treatment alternative for wide-necked bifurcation aneurysms, which are among the more difficult aneurysms to treat using other endovascular approaches.

"We are pleased to have achieved this important milestone in our ongoing efforts to develop our intellectual property portfolio," said Tom Wilder, President & CEO of Sequent Medical. "The utility of this patented braiding technology extends beyond the neurovascular field, and has the potential to address a number of unmet clinical needs."

About Sequent Medical, Inc.

Sequent Medical, Inc. (www.sequentmedical.com) is a privately held medical-device company that is dedicated to the development of innovative catheter-based neurovascular technologies.  The WEB Aneurysm Embolization System has received the CE mark, and is approved for use in several regions in addition to Europe.  It is not available for either investigational or commercial use in the United States.  Sequent Medical, Inc. is headquartered in Aliso Viejo, California, and has European operations based in Bonn, Germany.  Sequent licensed its MicroBraid technology to Inceptus Medical LLC (www.inceptusmedical.com) for use in select cardiovascular medical device applications.   


'/>"/>
SOURCE Sequent Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
3. ConvaTec Announces Acquisition of AbViser Medical, LLC
4. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
5. TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter
6. Nonin Medical, Inc. Announces U.S. Market Release of EQUANOX™ Advance Model 8004CB Series Sensor for Neonatal, Pediatric Patients
7. NexGen Biomedical, Inc. Provides New Insights Into Jett Travoltas Seizure Related Death
8. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
9. BioDrain Medical, Inc. Implements Initiatives to Position Itself for Sustained Growth
10. Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
11. Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... TAIPEI, Taiwan , March 28, 2017 /PRNewswire/ ... medical device company, is pleased to announce ... Series A investment of Panther Orthopedics, Inc., a ... pioneering innovative dynamic fixation solutions for orthopedic extremity ... market continues to expand rapidly, primarily due to ...
(Date:3/28/2017)...  "US Cancer Generics Market Outlook 2022" report ... trend analysis related to the emergence and integration ... in US. The report analyzes various clinical and ... generics drugs in recent years. The introduction of ... dollars for various stake holders involved US cancer ...
(Date:3/28/2017)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) today ... and year ended December 31, 2016. ... Orexigen, beginning with the re-acquisition of the rights to ... team at Orexigen demonstrated remarkable focus, executing on a ... our Company while rewarding us full control of our ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... ... Usually, the impending arrival of warmer weather means the gleeful banishment of ... chin, this means more anxiety than elation. The cosmetic dermatology experts at Cosmetic Laser ... chin is undesirable,” Dr. Goldman said, “but it seems doubly so when the fat ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, ... ensuring high-quality results and maintaining GMP and USP compliance. In a new webinar ... with GMP requirements " these requirements are explained. The challenge is to ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm , the mission-driven ... to a new, more expansive office space in order to accommodate its growing ... distressed office building in Wethersfield, Conn. located at 936 Silas Deane Highway and ...
(Date:3/28/2017)... ... 2017 , ... With less than 10,000 dermatologists in the United States and ... limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... March 28, 2017 , ... In its ongoing ... website has recently developed and published an informational resource that addresses frequently asked ... on common inquiries the site’s team of third party administrator (TPA) contributors regularly ...
Breaking Medicine News(10 mins):